TNL within the C-terminal domain of Fms as a novel autophosphorylation site. We demonstrate that this site constitutes a second Grb2 binding site: a recombinant fusion protein (residues 904 ± 944) containing phosphorylated Y921 bound Grb2 from FDCP1Mac11 cell extracts signi®cantly more eciently than a corresponding protein (residues 617 ± 759) containing Y696. A yeast two-hybrid system which allowed the formation of a functional Fms tyrosine kinase was employed to quantify binding of Grb2. Fms-protein containing either one of the two phosphorylation sites bound Grb2 equally well, binding was increased for proteins carrying both sites. In contrast, the simultaneous substitution of Y696 and Y921 by phenylalanines abolished Grb2 binding. Mouse NIH3T3 cells expressing the Y921F mutant Fms-protein showed a substantially higher content of ®bronectin network than wild-type transformed cells and had largely lost their serum independent growth phenotype.
Introduction
The v-fms oncogene of feline sarcoma virus encodes a modi®ed receptor tyrosine kinase which diers from its cellular counterpart, c-Fms, only in seven amino acid positions and in the C-terminal sequence (Hampe et al., 1984; Woolford et al., 1988; Smola et al., 1991) . Both proteins bind via their large extracellular domain the macrophage colony stimulating factor 1 (CSF-1, also termed M-CSF, Sherr et al., 1985) and share overall structural similarities with the platelet-derived growth factor (PDGF) receptor (Ullrich and Schlessinger, 1990 ). The c-and v-Fms molecules contain a cytoplasmic tyrosine kinase domain which is split into two subdomains, designated K1 and K2, by an insertion of approximately 70 amino acids, termed the kinase insert (KI) region. Furthermore, a segment of 35 amino acids, termed the juxtamembrane (JX) domain, separates the membrane spanning domain from the ®rst tyrosine kinase (K1) domain. Through two of the amino acid substitutions in the extracellular domain and the replacement of the C terminus, the vFms molecule is thought to have gained biochemical properties that are observed with the c-Fms protein only transiently upon binding to M-CSF (Woolford et al., 1988; Roussel et al., 1988) . Activation of the tyrosine kinase leads to autophosphorylation of the cytoplasmic domain of the Fms molecule at multiple sites. The newly formed phosphotyrosine residues constitute binding sites for SH2 domain-containing cytoplasmic proteins which may participate in the control of mitogenic pathways, cell metabolism, or cell morphology. The entire cytoplasmic domain of v-Fms (408 amino acids) contains 18 tyrosine residues all of which are conserved among human, mouse, feline, and chicken c-Fms. The c-Fms proteins, however, contain an additional tyrosine residue at the C-terminal end which is absent in v-Fms (Coussens et al., 1986; Rothwell and Rohrschneider, 1987; Woolford et al., 1988; Beug, personal communication) . Several autophosphorylation sites of the Fms molecules have been mapped. These include Y543 in the JX domain (Joos et al., 1996) , Y696, Y705, and Y720 (corresponding to Y697, Y706 and Y721 in the mouse c-Fms) in the KI domain, and Y807 in the K2 domain (Tapley et al., 1990; van der Geer and Hunter, 1990 Roussel et al., 1990; Reedijk et al., 1992; Trouliaris et al., 1995a,b; Joos et al., 1996) . Which are the cellular proteins that bind to these autophosphorylation sites? Y543 mediates association with a p55 polypeptide of yet unknown function (Joos et al., 1996) . The short segment of the KI domain encompassing Y696, Y705, and Y720, provides binding sites for Grb2 (van der Geer and Hunter, 1993) , STAT1 (Novak et al., 1996) , and the p85 subunit of phosphatidyl-inositol-3' (PI-3') kinase (Reedijk et al., 1992) , respectively. Furthermore, p120RasGAP was shown to bind to Y807 of v-Fms in phosphorylation-dependent manner (Trouliaris et al., 1995b) .
Studies designed to identify proteins that bind to the cytoplasmic domains of the epidermal growth factor (EGF)-and the PDGF-receptor led to the identification of proteins that acted uniformly, irrespective of the receptor type involved, in the transduction of the mitogenic signal. In nontransformed cells, a protein complex was detected that contained Grb2 and the nucleotide exchange factor Sos (Buday and Downward, 1993; Egan et al., 1993; Li et al., 1993; Rozakis-Adcock et al., 1993) . This protein complex binds via the SH2-domain of Grb2 to phosphotyrosine residues of the activated tyrosine kinase, allowing Sos to convert membrane-associated Ras to its GTP-bound form which subsequently binds and activates the serine/ threonine kinase Raf-1 (Daum et al., 1994) . Following a cascade of reactions in which additional serine/ threonine kinases become activated, MAP kinase ®nally induces transcription of a series of immediate early transcription factors including c-jun and c-fos.
In this paper, we identi®ed Y921 in the CT domain as a novel tyrosine autophosphorylation site of the Fms protein. We demonstrate that both Y696 in the KI domain and Y921 in the CT domain bind Grb2. A replacement of Y921 by phenylalanine induced serum dependency of v-Fms transformed cells.
Results

Tyrosine-921 is a tyrosine autophosphorylation site of vFms
Several receptor tyrosine kinases such as the receptors for EGF, PDGF, or insulin contain a C-terminal tyrosine residue in a position similar to Y921 of the Fms-polypeptide. For the other receptor types it has been established that these C-terminal tyrosines become phosphorylated upon receptor activation. Furthermore, it is clear that they constitute binding sites for various SH2 domain-containing proteins. No such information is available for Y921 of the v-and c-Fms molecules. To gain insight into the role of Y921, we ®rst analysed, whether a recombinant glutathione-S-transferase (GST)-v-Fms fusion protein containing this residue, GST-CT-v-Fms, was phosphorylated by v-Fms-speci®c immune complexes. Additional fusion proteins representing the JX domain (residues 535 ± 571 in GST-JX-Fms) or the KI domain (residues 617 ± 759 in GST-KI-Fms) were included as controls.
In vitro tyrosine kinase assays performed with equal amounts of immunoprecipitated v-Fms tyrosine kinase and aliquots of the individual GST-v-Fms fusion proteins as substrates indicated that all three GST-vFms polypeptides were phosphorylated on tyrosine (Figure 1a and b) . Since GST-KI-v-Fms contains three phosphorylation sites, it is not surprising that the phosphorylation of this substrate was about threefold stronger than that of the other two substrates which contain only a single phosphotyrosine residue. As shown in lane 5 of Figure 1a , a selective replacement of Y921 by phenylalanine abolished phosphorylation of GST-CT-Fms.
To further prove that Y921 was indeed one of the autophosphorylation sites, we compared the tryptic phosphopeptide patterns of full-length wt-v-Fms and Y921F-v-Fms molecules, as isolated from a v-Fms transformed cell line (wt-v-Fms cells) or a stably transfected NIH3T3 cell clone (Y921F-v-Fms cells). Both cell lysates were subjected to in vitro autophosphorylation reactions and the products were analysed by SDS-polyacrylamide gel electrophoresis (SDS ± PAGE) and tryptic peptide mapping. The Y921F mutation had neither an impact on the expression level of the mutant Fms protein nor did it aect its tyrosine kinase activity (Figure 2a and b) . The mutant lacked, however, two spots, designated`a' and`b' (Figure 2c ), in the phosphopeptide map. This indicates that also in the full-length v-Fms molecules tyrosine 921 becomes phosphorylated.
GST-KI-Fms and GST-CT-Fms fusion proteins associate with Grb2 in a tyrosine phosphorylation-dependent manner
The above results suggest that Y921 constitutes one of the autophosphorylation sites of the v-Fms polypeptide. A comparison of the amino acid sequencē anking Y921 with known SH2 binding consensus sequences (Songyang et al., 1994) KNI, share the asparagine residue in position +2. Furthermore, the polar nature of the residue in positon +1 and the hydrophobic property of the residue in the +3 position are conserved. Therefore, we next studied whether phosphorylated GST-pY-v-Fms fusion proteins, as isolated from E. coli strain TKX-1 (this strain expresses an active Elk tyrosine kinase) would pull down SH2-domain containing proteins from cell extracts. The corresponding non-phosphorylated control GST-fusion proteins were obtained from E. coli strain DH5a ( Figure 3b ). As a source for potential ligands, we employed lysates from the premyeloid FDCP-1Mac11 cell line (Gliniak and Rohrschneider, 1990) .
As a control for the eciency of this system, we studied whether the p85 subunit of PI-3'-kinase would bind to Y720 of the KI-domain. In agreement with previous reports (Reedijk et al., 1992; Joos et al., 1996) , such speci®c binding was indeed observed, provided that the GST-KI-Fms protein was phosphorylated ( Figure 3c ). As expected, some Grb2 was detected in the GST-pY-KI-Fms fraction (van der Geer and Hunter, 1993) . In comparison, however, the GST-pY-CT-Fms protein bound Grb2 signi®cantly stronger. This ®nding suggests that Y696 and Y921 constitute two independent binding sites for Grb2.
Both Y696 and Y921 of the Fms tyrosine kinase bind to the SH2 domain of Grb2 in a yeast two-hybrid system Our above observation that GST-pY-CT-Fms binds Grb2 from cell extracts more eciently than GST-pY-KI-Fms could be due to the presence of additional SH2-domain containing proteins known to bind to adjacent phosphotyrosines of the KI domain. Thus, STAT1 which associates with pY705 (Novak et al., 1996) or the p85 subunit of PI-3' kinase which binds, as just demonstrated to pY720 (Reedijk et al., 1992) could impose some steric hindrance for binding of Grb2. We, therefore, studied the interaction between Grb2 and Fms-polypeptides carrying pY696 or pY921 in a yeast two-hybrid system, i.e. under conditions where these potentially interfering proteins were absent. Furthermore, this system also provided insights as to whether the Grb2-Fms interaction occurred in the context of a living cell. To allow for a better quanti®cation of this interaction, we modi®ed a currently available screening system (Vojtek et al., 1993) and generated a yeast strain, YRN974, in which the reporter gene, encoding the green¯uorescent protein (GFP), was chromosomally integrated down- Figure 3 Grb2 binds to in vivo phosphorylated GST-KI-and GST-CT-Fms fusion proteins. GST, GST-KI-Fms, and GST-CTFms fusion proteins were isolated from E. coli strains TKX1 (TK) or DH5a (DH) as phosphorylated or nonphosphorylated proteins, respectively, and bound to GT-agarose beads. (a, b) Analyses of agarose bead fractions by 11% SDS ± PAGE and Coomassie brilliant blue staining (a), or by phosphotyrosine immunoblotting (b). (c) GT-agarose beads precharged with various GST-fusion proteins were incubated with cell lysates from 10 7 FDCP-1MAC11 cells, as detailed in Materials and methods, and analysed by SDS ± PAGE followed by immunoblotting, using monoclonal antibodies against p85 of PI-3'-kinase, or Grb2. Cell lysate (50 mg protein) from FDCP-1Mac11 was blotted as a positive control (Ly). Bound radioactivity was quanti®ed with a model BAS1500 bio-imaging analyser (Fuji Photo Film Co, Kanagawa, Japan). Protein bands which were stained with Coomassie blue were quanti®ed with the High Resolution Colour Scanner (Weidner et al., 1996) . The SH2 domain containing proteins to be tested for interaction with Fms contained a nuclear translocation signal attached to their N terminus. Activation of GFP was quanti®ed by¯ow cytometric analyses. To assess the speci®city of this system, we included three types of controls: First, we con®rmed that transformation with VP16 alone (lacking the gene for an SH2-domain containing protein) caused only background auto¯uorescence of YRN974 cells (Figure 4 , panels B and G). Second, we used a Fms-derivative in which the ATP-binding site was destroyed by a K613M substitution. As to be expected, this mutation prevented GFP-activation, both by Grb2 and by PI-3'-kinase, indicating that activation strictly requires tyrosine phosphorylation of the Fms-derivative. Third, as a positive control, we studied binding of the p85 subunit of PI-3'-kinase to the individual mutant Fms-polypeptides including one in which Y720 was replaced by phenylalanine. This latter mutation abolished GFP-activation through PI-3'-kinase, whereas that induced by Grb2 remained unaltered. As summarized in panel G of Figure 4 , mutations in positions 543 and 705 had no eect on the Grb2-or PI-3'-kinase-induced GFP-activation. The Y807F substitution aected the degree of activation through either ligand, suggesting that in this instance perhaps the tyrosine kinase activity of the mutant polypeptide was impaired. Mutations in position 696 or 921 had no eect on binding of PI-3'-kinase but reduced Grb2 binding to about the same extent (panels D, E, G). Binding of Grb2 was speci®cally abolished, however, when the two tyrosine residues were mutated simultaneously (panels F and G). This double mutant continued to bind to PI-3'-kinase ( Figure 4G ). These data clearly support our above data demonstrating that Y696 and Y921 constitute two independent binding sites for Grb2 in vivo.
Mutation of Y921 abolishes serum independent cell growth mediated by the v-Fms tyrosine kinase
What are the biological consequences of mutations of Y696 and Y921? Is binding of Grb2 to either of the two sites functionally equivalent? To address these questions, we next established NIH3T3 cell clones constitutively expressing either the wt-v-fms gene, the Y696-v-fms gene, or the Y921F-v-fms gene. Control experiments described in Figure 5 veri®ed that neither of the mutations aected the expression levels ( Figure  5a ) or the tyrosine kinase activity (Figure 5b ). To assess to what extent the altered Grb2-binding properties of the individual mutant v-Fms proteins interfered with the v-Fms-speci®c transforming potency, we further examined several dierent cell clones from each transfection for their ability to form colonies in soft agar and for growth at low serum concentrations. All clones tested gave identical results.
As observed with wt-v-Fms cells, the Y696F-and Y921F-v-Fms expressing cells continued to form colonies in soft agar. Their size, however was signi®cantly smaller than those formed by wt-v-Fms cells (dat not shown). Furthermore, in the presence of 1.5% FCS, the growth rate of both Y696F-v-Fms and Y921F-v-Fms cells was retarded (Figure 5c ). When the serum concentration was reduced to 0.5%, the Y921F-v-Fms cells failed to grow, whereas the Y696F-v-Fms expressing cells still multiplied 3.5-fold within 3 days (Figure 5d ). Wt-v-Fms cells show the transformed cell morphology characterized by a loss of the ®bronectin network (compare Figure 6E and F) . A removal of the Y696-speci®c Grb2 binding site had little, if any, eect on the ®bronectin network ( Figure 6G ). In contrast, the Y921F mutation largely restored the formation of a ®bronectin network, although the amount of fibronectin appeared still reduced in some areas of the monolayer ( Figure 6H ). 
Discussion
In this study we have identi®ed Y921 as a novel autophosphorylation site of the v-Fms receptor tyrosine kinase, and we show that this site forms a second binding site for the adaptor protein Grb2. This protein associates with a large number of receptor tyrosine kinases and plays a key role in the activation of the Ras/Raf-1 mitogenic signaling cascade. The notion that Y921 is the sixth autophosphorylation site of the Fms molecule is built on the collective evidence obtained through (i) in vitro phosphorylation tests combined with tryptic peptide mapping, (ii) the ability of recombinant phosphopeptides to speci®cally associate with Grb2 both in a pull-down assay and in a yeast two-hybrid screen and (iii) in the altered biological properties of a full-length v-Fms polypeptide specifically lacking this tyrosine residue.
Several attempts to demonstrate a direct interaction between Y921 and Grb2 by co-immunoprecipitation were met with failure. Previous studies had indicated, however, that under in vivo conditions the v-Fms proteins are phosphorylated on tyrosine only very transiently (Tamura et al., 1986) . Therefore, the pulldown assay involving the bacterially-derived GST-vFms phosphoprotein and the novel yeast two-hybrid approach provided the only possible access to demonstrate the Fms-Grb2 interaction and to quantify the degree of binding.
van der Geer and Hunter (1993) reported that Y696 of the KI domain represents a ®rst Grb2 binding site. Using the above-mentioned experimental approach, we con®rmed these data. However, additional studies performed with mouse NIH3T3 cells provided evidence that the KI domains of both the c-and the vFms tyrosine kinases were dispensable for their mitogenic and transforming activities (Taylor et al., 1989) . Along the same lines, Shurtle et al. (1990) showed that a deletion of the KI domain from the human c-Fms only reduced its mitogenic potency, again in mouse NIH3T3 cells. On the other hand, van der Geer and Hunter (1993) reported that a single point mutation at position 697 of mouse c-Fms (corresponding the Y696 in v-Fms) abolished the mitogenic signal in Rat2 cells. The authors explained this discrepancy by the dierent types of cell lines used in the dierent sets of experiments. Preliminary experiments based on in vitro phosphorylation reactions indicate that the feline c-Fms molecule is also phosphorylated on tyrosine 921 (A Mancini and T Tamura, unpublished observation). Thus, Y921 may function in transducing the Grb2-dependent mitogenic signal even when Y696 is deleted or not accessible for Grb2.
At this stage, we have no experimental evidence that would allow us to assign distinct biological properties to Grb2 molecules bound to Y696 versus those bound to Y921. Clearly, in mouse NIH3T3 cells the relative impact of Y921 appears to dominate that of Y696 in terms of transducing Grb2-dependent mitogenic signals. Thus, a mutation of Y921 prevents cells which express the mutant Fms protein from growing at low serum and largely restores the cellular ®bronectin network, while a mutation of Y696 has much less dramatic eects. However, we cannot exclude that the observed mitogenical and morphologic parameters are simply re¯ecting a Grb2-dose-dependency. Y696 is located in the close vicinity of two additional tyrosine autophosphorylation sites, Y705 and Y720, which associate with STAT1 and the p85 subunit of PI-3'-kinase, respectively. It is tempting to speculate that binding of any of the three ligands could in¯uence binding of the others, either through steric hindrance or binding-induced conformational changes. This In addition to binding Grb2, the PDGF receptor associates with Shp-2 or Shc both of which are contributing to a stimulation of the mitogenic Ras/ Raf-1 signaling pathway (Claesson-Welsh, 1994) . We have examined intensively, whether v-Fms interacts with Shc or Shp-2. However, we have been unable to detect such interactions by either the GST pull-down assay or the yeast two-hybrid screen. Our ®nding that the mutations of the two Grb2 binding sites drastically impaired the mitogenic potential of the v-Fms tyrosine kinase suggests that Grb2 is probably the exclusive Fms-associated modulator of the Ras/Raf-1 cascade. We cannot exclude, however, that a replacement of Y921 by phenylalanine induces an allosteric conformational change that would prevent an association of additional yet unde®ned adaptor proteins.
With respect to the Grb2-mediated control of the ®bronectin network, we cannot exclude the possibility that, depending on the tyrosine phosphorylation site occupied by Grb2, additional proteins are brought into the vicinity of the v-Fms tyrosine kinase. Indeed, following Fms activation, Grb2 was reported to form a complex with Sos, the focal adhesion kinase, Cbl, and dynamine (Kharbanda et al., 1995; Husson et al., 1997) . Therefore, it is possible that some of these additional proteins are directly engaged in the degradation of the ®bronectin network.
Materials and methods
Cells and antibodies
Mouse NIH3T3 cells, wt-v-Fms cells (NIH3T3 cells expressing the wild-type v-fms gene), or Y696F-, and Y921F-v-Fms cells (expressing mutant v-Fms proteins in which tyrosine in positions 696, or 921, respectively, was replaced by phenylalanine) were grown in Dulbecco modi®ed Eagle's medium (DMEM) supplemented with 10% FCS. FDCP-1Mac11 cells were maintained in DMEM supplemented with 10% FCS and WEHI3BD-conditioned medium as a source of interleukin-3 at a concentration that stimulated optimal cell growth.
An anti-v-Fms antiserum was used as described previously (Tamura et al., 1986) . Monoclonal antibodies against phosphotyrosine (4G10) and the p85 subunit of PI-3'-kinase were purchased from Upstate Biotechnology Incorporated (Lake Placid, NY). Monoclonal antibody against Grb2 was from Transduction Laboratory (Lexington, KY).
Plasmid constructions and transfection procedures
Generation of the Y543F, K613M, Y696F, Y705F, Y720F, Y807F, and Y921f mutations and transfection of eukaryotic cells were performed as described previously (Trouliaris et al., 1995a,b; Joos et al., 1996) . For expression of wt-and mutant v-Fms in yeast cells, LexAv-Fms fusion proteins were generated in the pBTM116. The v-fms speci®c DNA-segment encoded amino acid residues 536 ± 944 which fold ± upon LexA-induced dimerization ± into an active tyrosine kinase. In addition, binding partners of v-Fms were generated in pVP16 which contained cDNA encoding the SH2 domain of PI-3'-kinase or Grb2 (Vojtek et al., 1993) .
Several GST-v-Fms fusion proteins were generated in the pGex system (Pharmacia, Freiburg, Germany) which contained various v-Fms sequences at their C terminus: GST-JXFms contained residues 535 ± 571; GST-KI-Fms contained residues 617 ± 759; GST-CT-Fms contained residues 904 ± 944 with and without Y921F mutation (for numbering of amino acid residues, see Smola et al., 1991) . Concentrations of the GST-fusion proteins were determined with a Model Sharp JX-325 scanner (Sharp JX-325, Pharmacia Biotech. Freiburg, Germany) using Coomassie-stained acrylamide gels using bovine serum albumin as a standard.
Binding assay using two-hybrid system Quanti®cation of two-hybrid protein/protein interactions will be described in greater detail elsewhere (Niedenthal et al., in preparation) . Brie¯y, yeast strain YRN974 with an integrated LexA-Operator-GFP cassette (yEGFP3, Cormack et al., 1996 Cormack et al., , 1997 was transformed with two plasmids: pBTM116 carrying cDNAs encoding wt-or mutant v-Fms downstream from a lexA-segment, and pVP16 carrying Grb2 or PI-3'-kinase genes. Proteins arising from this latter vector carried an N-terminal nuclear translocation signal. Ten thousand cells of four independent transformants were analysed for¯uorescence intensity using a Becton Dickinson FACScan¯ow cytometer (Niedenthal et al., 1996) .
Binding of cellular proteins to phosphorylated GST-v-Fms fusion proteins and immunoblot analyses
Strain TKX-1 (Stratagene, La Jolla) was used for the isolation of phosphorylated GST-Fms fusion proteins. GST-fusion proteins were isolated as recommended by the manufacturer. The corresponding nonphosphorylated molecular species were isolated from E. coli DH5a. Puri®ed GST fusion proteins were bound for 1 h at 48C to glutathione (GT) agarose beads (40 ml slurry; Pharmacia) suspended in binding buer (50 mM HEPES, pH 7.5, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1.5 mM MgCl 2 , 1 mM EGTA, 1% Trasylol, 100 mg/ml leupeptin, 1 mM phenylmethylsulfonyl¯uoride, 200 mM sodium orthovanadate, 10 mM sodium pyrophosphate, and 100 mM sodium¯uoride). Precharged beads were incubated overnight at 48C with lysate from FDCP-1Mac11 cells in a total volume of 2 ml of binding buer. Beads were washed ®ve times with binding buer and pellets were analysed by SDS ± PAGE. For identi®cation of proteins by immunoblotting, proteins were transferred onto Immobilon-P sheets (Millipore, Bedford, MA) by a semi-dry blotting technique. Bound antibody was visualized by incubation of blots in 3 ml of 20 mM Tris-HCl, pH 7.6, containing 137 mM NaCl and 2 mCi of 125 I-labeled anti-species-speci®c immunoglobulin G (IgG, ICN) . Bound radioactivity was quanti®ed with a model BAS1500 bio-imaging analyzer (Fuji Photo Film Co, Kanagawa, Japan). Protein bands, stained with Coomassie blue, were quanti®ed with a High Resolution Colour Sharp JX-325 Scanner.
Kinase assays, phosphoamino acid analyses and tryptic peptide mapping Fms-speci®c immune complexes were incubated for 20 min at room temperature with 3 mCi of [g-32 P]-ATP (Amersham Buchler, Braunschweig, Germany) in the presence of 10 mM MnCl 2 and analysed by SDS±PAGE. For phosphoamino acid analyses, material was eluted from the gels and hydrolyzed for 2 h in 6 M HCl at 1108C. Samples were analysed by two-dimensional electrophoresis (Tamura et al., 1990) . For tryptic peptide mapping, the material was digested with trypsin (300 mg/ml) for 20 h. Products were analysed by two-dimensional electrophoresis and chromatography, as described (Joos et al., 1996) .
